Montreal, Quebec--(Newsfile Corp. - July 30, 2026) - Alithya Group inc. (TSX: ALYA) ("Alithya") will report on August 13, 2026, its financial results for the first quarter of fiscal 2027 ended June 30, 2026.Alithya will host a conference call, follow

– COMO and CAPRI trials together rapidly enrolled over 480 participants in five months, demonstrating continued enthusiasm for DURAVYU trial participation among retinal specialists and patients –– – Topline 56-week data for both DME trials anticipate

Business Combination Agreement to Bring Nuclea's Lead-Cooled Morpheus Microreactor to the Public Markets Amid Surging Power Demand from AI and Data Centers DALLAS, TEXAS, July 30, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoce

NEWARK, N.Y., July 30, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2026, before the market opens on Friday, August 7, 2026. Ultralife’s Management will also host a

Chicago-based security leader adopts immersive virtual reality training as WrapShield™ expands into the growing private security market with solutions designed to improve decision-making, reinforce policy, and promote safer outcomesMIAMI, July 30, 20

$10.2 million upfront with up to $10.0 million of short-term warrants, accelerated upon FDA clearance; financing also includes an additional $10.0 million in long-term warrantsGARDEN CITY, N.Y., July 30, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NAS

Winnipeg, Manitoba--(Newsfile Corp. - July 30, 2026) - Gossan Resources Limited (TSXV: GSS) (FSE: GSR) (XETRA: GSR) (the "Company" or "Gossan") is pleased to announce the release of its annual Audited Consolidated Financial Statements and accompanyin

Vancouver, British Columbia--(Newsfile Corp. - July 30, 2026) - Rua Gold Inc. (TSX: RUA) (NZX: RGI) (OTCQX: NZAUF) (FSE: X9R) ("RUA GOLD" or the "Company") is pleased to announce that the Auld Creek Project, located in the Reefton Goldfield, New Zeal

Toronto, Ontario--(Newsfile Corp. - July 30, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (OTCQB: TMPTF) (FSE: 9DY) ("TempraMed" or the "Company") is pleased to announce that its common shares have been approved to commence trading on the OTCQB Ve

Quarterly revenue of US$918K, representing an increase of 28% year-over-yearImprovements to Adjusted EBITDA1 margin while driving investments in growth opportunitiesFY2027 focused on delivering traction in Small Modular Reactor (SMR) nuclear energy i